FBXO43 and hepatocellular carcinoma: Moreover, HCC patients with high FBXO43 expression had a poor prognosis in terms of overall survival (OS), disease-specific survival (DSS), progress-free interval survival (PFI), and relapse-free survival (RFS) (Figure 1E,F and Supplementary Figure S1D–E).